Amyloidosis

References

• Glenner G. G. Amyloid deposits and amyloidosis. The beta fibrilloses. N Engl J Med 1980; 302: 1283–1333
   PubMed Web of Science ®Google Scholar
• Husby G., Sletten K. Amyloidosis. Scand J Immunol 1986; 23: 253–65
   PubMed Web of Science ®Google Scholar
• Kisilevsky R. From arthritis to Alzheimer's disease: Current concepts on the pathogenesis of amyloidosis. Can J Physiol Pharm 1987; 65: 1805–15
   PubMed Web of Science ®Google Scholar
• Cohen A. S. Amyloidosis. Arthritis and allied conditions12th ed., D. J. McCarty, W. J. Koopman. Lea and Febiger, Philadelphia 1993; 1427–1447
   Google Scholar
• Benditt E. P., Eriksen N, Meek R. L. Serum amyloid A protein. Methods Enzymol 1988; 163: 510–23
   PubMed Web of Science ®Google Scholar
• Castano E. M., Frangione B. Human amyloidosis, Alzheimer disease and related disorders. Lab Invest 1988; 58: 122–32
   PubMed Web of Science ®Google Scholar
• Cathcart E. S. Amyloidosis. Textbook of rheumatology, W. N. Kelly, E. D. Harris, S. Ruddy, et al. W.B. Saunders, Philadelphia 1993; 1412–1428
   Google Scholar
• Sipe J. D. Amyloidosis. Ann Rev Biochem 1992; 61: 947–975
   PubMed Web of Science ®Google Scholar
• Kisilevsky R, et al. Amyloid and amyloidosis 1993, R. Kisilevsky. Parthenon Press, New York 1994
   Google Scholar
• Benditt E. P. Amyloid protein AA and its precursor, the acute phase protein(s) apoSAA: a perspective. Amyloidosis, J. Marrink, M. H. van Rijswijk. Martinus Nijhoff, Dordrecht 1986; 101–106
   Google Scholar
• Glenner G. G., Page D. L. Amyloid, amyloidosis, and amyloidogenesis. Int Rev Exp Pathol 1976; 15: 2–92
   Google Scholar
• Natvig J. B., Forre O., Husby G., et al. Amyloid and amyloidosis, 1990, J. B. Natvig, O. Forre, G. Husby. Kluwer, Dordrecht 1991; 1–922
   Google Scholar
• Virchow R. Bau und zusammensetzung der corpora amylacea des menschen. Verh Pkys Med Ges Wurzburg 1851; 2: 51–4
   Google Scholar
• Friedreich N., Kekule A. Zur amyloidfrage. Arch Pathol Physiol Klin Med 1859; 16: 50–65
   Google Scholar
• Snow A. D., Willmer J, Kisilevsky R. Sulfated glycosaminoglycans: a common constituent of all amyloids%. Lab Invest 1987; 56: 120–3
   PubMed Web of Science ®Google Scholar
• Sorenson G. D., Shimamura T. Experimental amyloidosis. HI. Light and electron microscopic observations of renal glomeruli. Lab. Invest 1964; 13: 409–17
   Web of Science ®Google Scholar
• Husebekk A., Skogen B. Degradation of SAA in amyloid fibrils by elastase. Amyloid and amyloidosis, 1990, J. B. Natvig, O. Forre, G. Husby, et al. Kluwer, Dordrecht 1991; 107–110
   Google Scholar
• Glenner G. G., Keiser H. R., Bladen H. A., et al. Amyloid. VI. A comparison of two morphologic components of human amyloid deposits. J Histochem Cytochem 1968; 16: 633–44
   PubMed Web of Science ®Google Scholar
• Trainin E. B., Spitzer A, Greifer I. Amyloidosis in juvenile rheumatoid arthritis. NY State J Med 1978; 78: 72–7
   PubMedGoogle Scholar
• Christmanson L., Betsholtz C., Gustavsson A., et al. The transthyretin cDNA sequence is normal in transthyretin-derived senile systemic amyloidosis. FEBS Lett 1991; 281: 177–80
   PubMed Web of Science ®Google Scholar
• Gejyo F., Homma N., Suzuki Y., et al. Serum levels of β2-microglobulin as a new form of amyloid protein in patients undergoing long-term hemodialysis. N Engl J Med 1986; 314: 585–6
   PubMed Web of Science ®Google Scholar
• Kirschner D. A., Abraham C, Selkoe D. J. X-ray diffraction from intraneuronal paired helical filaments and extraneuronal amyloid fibers in Alzheimer disease indicated cross-B conformation. Proc Natl Acad Sci USA 1985; 82: 1–5
   PubMedGoogle Scholar
• Glenner G. G., Murphy M. Amyloidosis of the nervous system. J Neurol Sci 1989; 94: 1–28
   PubMed Web of Science ®Google Scholar
• Kisilevsky R. Amyloidosis: a familiar problem in light of the current pathogenetic developments. Lab Invest 1983; 49: 381–9
   PubMed Web of Science ®Google Scholar
• Deal C. L., Sipe J. D., Tatsuta E., et al. The effect of amyloid enhancing factor (AEF) on the acute phase serum amyloid A (SAA) and serum amyloid P (SAP) response to silver nitrate. Ann NY Acad Sci 1982; 389: 439–41
   Web of Science ®Google Scholar
• Cohen A. S., Calkins E. Electron microscopic observations on a fibrous component in amyloid of diverse origins. Nature 1959; 183: 1202–3
   PubMed Web of Science ®Google Scholar
• Pras M., Schubert M., Zucker-Franklin D., et al. The characterization of soluble amyloid prepared in water. J Clin Invest 1968; 47: 924–33
   PubMed Web of Science ®Google Scholar
• Glenner G. G., Eanes E. D., Bladen H. A., et al. Beta-pleated sheet fibrils. A comparison of native amyloid with synthetic protein fibrils. J Histochem Cytochem 1974; 22: 1141–58
   PubMed Web of Science ®Google Scholar
• Bonar L., Cohen AS, Skinner M. M. Characterization of the amyloid fibril as a cross-beta protein. Proc Soc Exp Biol Med 1969; 131: 1373–5
   PubMed Web of Science ®Google Scholar
• Keizman I. K., Ravid M, Sohar E. In vitro synthesis of “amyloid” fibrils from insulin, calcitonin and parathormone. Isr J Med Sci 1976; 12: 1137–40
   PubMedGoogle Scholar
• Termine J. D., Eanes E. D., Ein D., et al. Infrared spectroscopy of human amyloid fibrils and immunoglobulin proteins. Biopolymers 1972; 11: 1103–13
   PubMed Web of Science ®Google Scholar
• Glenner G. G., Eanes ED, Page D. L. The relations of the properties of Congo red-stained amyloid fibrils to the beta-conformation. J Histochem Cytochem 1972; 20: 821–6
   PubMed Web of Science ®Google Scholar
• Pauling L., Corey R. B. Two rippled-sheet configurations of polypeptide chains, and a note about the pleated sheets. Proc Natl Acad Sci USA 1953; 39: 253–6
   PubMed Web of Science ®Google Scholar
• Kidd M. Paired helical filaments in electron microscopy of Alzheimer's disease. Nature 1963; 197: 192–3
   PubMed Web of Science ®Google Scholar
• Gorevic P. D., Goni F., Pons-Estel B., et al. Isolation and partial characterization of neurofibrillary tangles and amyloid plaque core in Alzheimer's disease: immunohistological studies. J Neuropathol 1986; 45: 647–64
   PubMed Web of Science ®Google Scholar
• McCubbin W. D., Kay C. R., Narindrasorasak S., et al. Circular-dichroism studies on two murine serum amyloid A proteins. Biochem J 1988; 256: 775–83
   PubMed Web of Science ®Google Scholar
• Snow A. D., Wight T. N. Proteoglycans in the pathogenesis of Alzheimer's disease and other amyloidosis. Neurobiol Aging 1989; 10: 481–97
   PubMed Web of Science ®Google Scholar
• Kisilevsky R. Theme and variations on a string of amyloid. Neurobiol Aging 1989; 10: 499–500
   PubMed Web of Science ®Google Scholar
• Teilum G. Cortisone-ascorbic acid interaction and the pathogenesis of amyloidosis. Mechanism of action of cortisone on mesenchymal tissue. Ann Rheum Dis 1952; 11: 119–36
   PubMed Web of Science ®Google Scholar
• Shirahama T. Intralysosomal formation of amyloid fibrils. Am J Pathol 1975; 81: 101–16
   PubMed Web of Science ®Google Scholar
• Shirahama T., Cohen A. S. Lysosomal breakdown of amyloid fibrils by macrophages. Am J Pathol 1971; 63: 463–85
   PubMed Web of Science ®Google Scholar
• Richter G. The resorption of amyloid under experimental conditions. Am J Pathol 1954; 30: 239–51
   PubMed Web of Science ®Google Scholar
• Williams G. Histological studies in resorption of experimental amyloid. J Pathol Bacteriol 1967; 94: 331–6
   PubMedGoogle Scholar
• Zucker-Franklin D. Amyloidosis: molecular insights and cellular blindspots. Amyloid and amyloidosis, 1990, J. B. Natvig, O. Forre, G. Husby, et al. Kluwer, Dordrecht 1991; 917–920
   Google Scholar
• Chronopoulos S., Alizadeh-Khiavi KN J. Ali-Khan Z. Binding of ubiquitin to experimentally induced murine AA amyloid. J Pathol 1991; 163: 199–203
   PubMed Web of Science ®Google Scholar
• Perry G., Friedman R., Shaw G., et al. Ubiquitin is detected in neurofibrillary tangles and senile plaque neurites of Alzheimer disease brains. Proc Natl Acad Sci USA 1987; 84: 3033–6
   PubMed Web of Science ®Google Scholar
• Fried VA, Smith H. T., Hildebrandt E., et al. Ubiquitin has intrinsic proteolytic activity: implications for cellular regulation. Proc Natl Acad Sci USA 1987; 84: 3685–9
   PubMed Web of Science ®Google Scholar
• Skinner M., Stone P. J., Shirahama T., et al. The association of an elastase with amyloid fibrils. Proc Soc Exp Biol Med 1986; 181: 211–4
   PubMed Web of Science ®Google Scholar
• Skinner M., Shirahama T., Cohen A. S., et al. The association of amyloid P-component (AP) with the amyloid fibril: an updated method for amyloid fibril isolation. Prep Biochem 1983; 12: 461–76
   Google Scholar
• Glenner G. G., Wong C. W. Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophy Res Comm 1984; 120: 855–90
   Web of Science ®Google Scholar
• Selkoe D. J., Abraham C. R. Isolation of paired helical filaments and amyloid fibers from human brain. Methods Enzymol 1986; 134: 388–404
   PubMed Web of Science ®Google Scholar
• Wong C. W., Quaranta V, Glenner G. G. Neuritic plaques and cerebrovascular amyloid in Alzheimer disease are antigenically related. Proc Natl Acad Sci USA 1985; 82: 8729–32
   PubMed Web of Science ®Google Scholar
• Prelli F., Castano E., Glenner G. G., et al. Differences between vascular and plaque core amyloid in Alzheimer's disease. J Neurochem 1988; 51: 648–51
   PubMed Web of Science ®Google Scholar
• Kang J., Lemaire H. G., Unterback A., et al. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature 1987; 325: 733–6
   PubMed Web of Science ®Google Scholar
• Selkoe D. Amyloid beta-protein deposition as a seminal pathogenetic event in Alzheimer's disease. Amyloid and amyloidosis 1990, J. B. Natvig, O. Forre, G. Husby, et al. Kluwer, Dordrecht 1991; 713–7
   Google Scholar
• Divry P., Florkin M. Sur les Proprieties optiques de l'amyloide. CR Soc Biol 1927; 97: 1808–10
   Google Scholar
• Doolittle R. F. Fibrinogen and fibrin. The plasma proteins, F. W. Putnam. Academic Press, New York 1975; 62–110
   Google Scholar
• Davie E. W., Hanahan D. J. Blood coagulation proteins. The plasma proteins, F. W. Putnam. Academic Press, New York 1975; 422–444
   Google Scholar
• Elghetany M. T., Saleem A. Methods for staining amyloid in tissues: a review. Stain Technol 1988; 63: 201–12
   PubMed Web of Science ®Google Scholar
• Wolman M. Amyloid, its nature and molecular structure. Comparison of a new toluidine blue polarized light method with traditional procedures. Lab Invest 1971; 25: 104–10
   PubMed Web of Science ®Google Scholar
• Mathews M. B., Decker L. The effect of acid mucopolysaccharides and acid mucopolysac-charide-proteins on fibril formation from collagen solutions. Biochem J 1968; 109: 26–517
   Web of Science ®Google Scholar
• Obrink B. The influence of glycosaminoglycans on the formation of fibers from monomeric tropocollagen in vitro. Eur J Biochem 1973; 34: 129–37
   PubMedGoogle Scholar
• Gelman R. A., Blackwell J, Mathews M. B. Interactions of an intact proteoglycan and its fragments with basic homopolypeptides in dilute aqueous solution. BiochemJ 1974; 141: 445–54
   PubMed Web of Science ®Google Scholar
• Puchtler H., Sweat F, Levine M. On the binding of Congo red by amyloid. J Histochem Cytochem 1962; 10: 355–64
   Web of Science ®Google Scholar
• Cooper J. H. An evaluation of current methods for the diagnostic histochemistry of amyloid. J Clin Pathol 1969; 22: 419–3
   Web of Science ®Google Scholar
• DeLellis R. L., Bowling M. C. The use of sirius red and Congo red staining in routine histopathology. Hum Pathol 1970; 1: 655
   PubMedGoogle Scholar
• Breathnach S. M., Melrose S. M., Bhogal B., et al. Amyloid P component is located on elastic fibre microfibrils in normal human tissue. Nature 1981; 293: 652–4
   PubMed Web of Science ®Google Scholar
• Dyck R. F., Lockwood C. M., Kershaw M., et al. Amyloid P component is a constituent of normal human glomerular basement membrane. J Exp Med 1980; 152: 1162–74
   PubMed Web of Science ®Google Scholar
• Husby G., Araki S., Benditt E. P., et al. The 1990 guidelines for nomenclature and classification of amyloid and amyloidosis. Amyloid and amyloidosis, 1990, J. B. Natvig, O. Forre, G. Husby. Kluwer, Dordrecht 1991; 7–11
   Google Scholar
• Glenner G. G., Harbaugh J., Ohms J. I., et al. An amyloid protein: the amino-terminal variable fragment of an immunoglobulin light chain. Biochem Biophys Res Comm 1970; 41: 1287–9
   PubMed Web of Science ®Google Scholar
• Cohen A. S. Amyloidosis. New Engl J Med 1967; 277: 522, 574,638
   PubMed Web of Science ®Google Scholar
• Page D. L., Isersky C., Horada M., et al. Immunoglobulin origin of localized nodular pulmonary amyloidosis. Res Exp Med 1972; 159: 75–86
   PubMedGoogle Scholar
• Husby G., Sletten K., Blumenkrantz N., et al. Characterization of an amyloid fibril protein from localized amyloidosis of the skin as lambda immunoglobulin light chains of variable subgroup (A lambda I). Clin Exp Immunol 1981; 45: 90–6
   PubMed Web of Science ®Google Scholar
• Eulitz M., Linke R. P. The precursor molecule of a Vlambda II-immunoglobulin light chain-derived amyloid fibril protein circulates precleaved. Biochem Biophys Res Comm 1993; 194: 1427–34
   PubMed Web of Science ®Google Scholar
• Eulitz M., Linke R. Amyloid fibrils derived from V-region together with C-region fragments from a lambdall-immunoglobulin light chain (HAR). Hoppe-Seyler Biol Chem 1985; 366: 907–15
   PubMed Web of Science ®Google Scholar
• Buxbaum J., Caron D, Gallo G., Amyloid AL. L-chain and L and H-chain deposition diseases: comparison of Ig synthesis and tissue deposition. Amyloid and amyloidosis 1990, J. B. Natvig, O. Forre, G. Husby, et al. Kluwer, Dordrecht 1991; 197–200
   Google Scholar
• Solomon A., Frangione B, Franklin E. C. Bence Jones proteins and light chains of immunoglobulins. Preferential association of die V lambda VI subgroup of human light chains with amyloidosis AL(lambda). J Clin Invest 1982; 70: 453–60
   PubMed Web of Science ®Google Scholar
• Comwell G. G., Thomas B., Kyle R. A., et al. Clinicopathologic correlations in 109 patients with systemic amyloidosis studied by immunocytochemistry. Amyloid and amyloidosis 1990, J. B. Natvig, O. Forre, G. Husby. Kluwer, Dordrecht 1991; 203–6
   Google Scholar
• Liepnieks J. J., Benson M. D., Dwulet F. E. Comparison of the amino acid sequences of ten kappa I amyloid proteins for amyloidogenic sequences. Amyloid and amyloidosis 1990, J. B. Natvig, O. Forre, G. Husby, et al. Kluwer, Dordrecht 1991; 153–156
   Google Scholar
• Kabat E. A., Wu T. T., Reid-Miller M., et al. Sequences of proteins of immunological interest. NIH, Bethesda 1987; 63–292
   Google Scholar
• Kyle R. A. Primary systemic amyloidosis (AL) in 1990. Amyloid and amyloidosis 1990, J. B. Natvig, O. Forre, G. Husby, et al. Kluwer, Dordrecht 1991; 147–152
   Google Scholar
• Benson M. D., Hamilton JA, Murrell J. X-ray crystallographic analysis of an AL kappa light chain to 2A resolution. VIIth International Symposium on Amyloidosis (Abstract) 1993
   Google Scholar
• Gallo G., Picken M., Frangione B., et al. Nonamyloidotic monoclonal immunoglobulin deposits lack amyloid P-component. Mol Pathol 1988; 1: 453–6
   Google Scholar
• Solomon A., Kyle RA, Frangione B. Light chain variable region subgroups of monoclonal immunoglobulins in amyloidosis AL. Amyloidosis, G. G. Glenner, E. F. Osserman, E. P. Benditt, et al. Plenum Press, New York 1986; 462–449
   Google Scholar
• Glenner G. G., Ein D., Eanes E. D., et al. Creation of “Amyloid” fibrils from Bence Jones proteins in vitro. Science 1971; 174: 712–4
   PubMed Web of Science ®Google Scholar
• Linke R. P., Tischendorf F. W., Zucker-Franklin D., et al. The formation of amyloid-like fibrils in vitro from Bence Jones proteins of the lambda I subclass. J Immunol 1973; 111: 24–6
   PubMed Web of Science ®Google Scholar
• Eulitz M., Breuer M., Eblen A., et al. Production of amyloidogenic peptides from human immunoglobulin light (L)-chains. Amyloid and amyloidosis 1990, J. B. Natvig, O. Forre, G. Husby. Kluwer, Dordrecht 1991; 505–510
   Google Scholar
• Cohen A. S., Connors L. H. The pathogenesis and biochemistry of amyloidosis. J Pathol 1987; 151: 1–10
   PubMed Web of Science ®Google Scholar
• Toft K. G., Olstad O. K., Sletten K., et al. Comparative studies of two AL chains of kappa-III light chain origin with and without attached carbohydrate (ALSol24 and AL 700). Amyloid and amyloidosis 1990, J. B. Natvig, O. Forre, G. Husby. Kluwer, Dordrecht 1991; 169–172
   Google Scholar
• Koss M. N., Pirani C, Osserman E. F. Experimental Bence Jones cast nephropathy. Lab Invest 1976; 34: 579–91
   PubMed Web of Science ®Google Scholar
• Solomon A., Weiss D. T. Experimental production of human amyloidosis AL. Amyloid and amyloidosis 1990, J. B. Natvig, O. Forre, G. Husby, et al. Kluwer, Dordrecht 1991; 193–6
   Google Scholar
• Linke R. P., Bock V., Vaiet G., et al. Inhibition of the oxidative burst response of. N-formyl peptide-stimulated neutrophils by serum amyloid-A protein. Biochem Biophys Res Comm. 1991; 176: 1100–5
   PubMed Web of Science ®Google Scholar
• Benditt E. P., Eriksen N., Hermodson MA, et al. The major proteins of human and monkey amyloid substance: common properties including unusual N-terminal amino acid sequences. FEBS Lett 1971; 19: 169–73
   PubMed Web of Science ®Google Scholar
• McAdam KPWJ, Sipe J. D. Murine model for human secondary amyloidosis: genetic variability of the acute-phase serum protein SAA response to endotoxins and casein. J Exp Med 1976; 144: 1121–7
   PubMed Web of Science ®Google Scholar
• Sipe J. D. Induction of the acute-phase serum protein SAA requires both RNA and protein synthesis. Br J Exp Pathol 1978; 59: 305–10
   PubMedGoogle Scholar
• Morrow J. F., Stearman R. S., Peltzman C. G., et al. Induction of hepatic synthesis of serum amyloid A protein and actin. Proc Natl Acad Sci USA 1981; 78: 4718–22
   PubMed Web of Science ®Google Scholar
• Tape C., Tan R., Nesheim M., et al. Direct evidence for circulating apoSAA as the precursor of tissue AA amyloid deposits. Scand J Immunol 1988; 28: 317–24
   PubMed Web of Science ®Google Scholar
• Husby G., Sletten K. Chemical and clinical classification of amyloidosis 1985. Scand J Immunol 1985; 23: 253–65
   Web of Science ®Google Scholar
• Faulkes D. J., Berts JC, Woo P. Genetic polymorphisms of SAA1. VIIth International Symposium on Amyloidosis (Abstract) 1993
   Google Scholar
• Kluve-Beckerman B., Long GL, Benson M. D. DNA sequence evidence for polymorphic forms of human serum amyloid A. Biochem Genet 1986; 24: 795–803
   PubMed Web of Science ®Google Scholar
• McAdam KPWJ, Elin R. J., Sipe J. D., et al. Changes in human serum amyloid A and C-reactive protein following etiocholanolone-induced inflammation. J Clin Invest 1978; 66: 390–4
   Google Scholar
• Eriksen N., Benditt E. P. Isolation and characterization of human serum amyloid A proteins. Proc Natl Acad Sci USA 1980; 77: 6860–4
   PubMed Web of Science ®Google Scholar
• Bausserman L. L. Herbert PN McAdam KPWJ.Heterogeneity of human serum amyloid A proteins. J Exp Med 1980; 152: 641–6
   PubMed Web of Science ®Google Scholar
• Dubois D. Y., Malmendier C. L. Non-competitive enzyme-linked immunosorbent assay for human apolipoprotein SAA or. S. J Immunol Methods 1988; 112: 71–5
   PubMed Web of Science ®Google Scholar
• Strachan A. F., Brandt W. F., Woo P., et al. The assignment of the six major isoforms to three published gene sequences and evidence for two genetic loci. J Biol Chem 1989; 264: 18368–73
   PubMed Web of Science ®Google Scholar
• Hoffman J. S., Benditt E. P. Changes in high-density lipoprotein content following endotoxin administration in the mouse. J Biol Chem 1982; 57: 10510–17
   Google Scholar
• Coetzee G. A., Strachan A. F., van der Westhuyzen D., et al. Serum amyloid A-containing human high density lipoprotein 3. J Biol Chem 1986; 261: 9644–51
   PubMed Web of Science ®Google Scholar
• Strachan A. F., de Beer F. C., Coetzee G. A., et al. Characteristics of apo-SAA-containing HDL3 in humans. Protides Biol Fluids Coll 1986; 34: 359–62
   Google Scholar
• Ganapathi M. K., Rzewnicki D., Samols S., et al. Effect of combinations of cytokines and hormones on synthesis of serum amyloid A and C-reactive protein in Hep 3B cells. J Immunol 1991; 147: 1261–5
   PubMed Web of Science ®Google Scholar
• Woo P., Sipe J., Dinarello C. A., et al. Structure of a human serum amyloid A gene and modulation of its expression in transfected L cells. J Biol Chem 1988; 262: 15790–5
   Web of Science ®Google Scholar
• Rokita H., Loose L. D., Bartle L. M., et al. Synergism of interleukin 1 and interleukin 6 induces serum amyloid A (SAA) production while depressing fibrinogen: a quantitative analysis. J Rheumatol 1993, (in press)
   Web of Science ®Google Scholar
• Sipe J. D., de Beer F. C., Pepys M., et al. Report of special session on bioassay and standardization of amyloid proteins and precursors. Amyloid and amyloidosis 1990, J. B. Natvig, O. Forre, G. Husby. Kluwer, Dordrecht 1991; 883–889
   Google Scholar
• Woo P., Betts J, Edbrooke M. The human serum amyloid A genes and their regulation by inflammatory cytokines. Amyloid and amyloidosis 1990, J. B. Natvig, O. Forre, G. Husby, A. Husebekk, B. Skogen, K. Sletten. Kluwer, Dordrecht 1991; 13–19
   Google Scholar
• Benditt E. P., Meek RL, Eriksen N. ApoS AA: structure, tissue expression and possible functions. Acute phase proteins in the acute phase response, M. B. Pepys. Springer-Verlag, London 1989; 59
   Google Scholar
• Hayes K. C., Lim M., Pronczuk A., et al. Disruption in lipoprotein metabolism during the acute phase response in hamsters. FASEB J 1991; 5: A1287
   Web of Science ®Google Scholar
• Liang J-S, Sipe J. D. Recombinant human serum amyloid A (apoSAAp.) binds cholesterol and modulates cholesterol flux. J Lipid Res, (in press)
   Google Scholar
• Fife A., Lusis AJ, Fogelman A. M. SAA levels correlate with presence of posttransplant coronary disease. Biology of the Vascular Wall. American Heart Association(Abstract). 1993
   Google Scholar
• Gonnerman W. A., Cathcart E. S., Sipe J. D., et al. Increased binding of acute phase lipoproteins by peritoneal macrophages (MO) in mice. Amyloid and amyloidosis 1990, J. B. Natvig, O. Forre, G. Husby. Kluwer, Dordrecht 1991; 547–550
   Google Scholar
• Kisilevsky R., Subrhmanyan L. Serum amyloid A changes high density lipoprotein's cellular affinity. A clue to serum amyloid A's principal function. Lab Invest 1992; 66: 778–85
   PubMed Web of Science ®Google Scholar
• Benditt E. P., Eriksen N, Hanson R. H. Amyloid protein SAA is an apoprotein of mouse plasma high-density lipoprotein. Proc Natl Acad Sci USA 1979; 76: 4092–6
   PubMed Web of Science ®Google Scholar
• Zimlichman S., Danon A., Nathan I., et al. Serum amyloid A, an acute phase protein, inhibits platelet activation. J Lab Clin Med 1990; 116: 180–6
   PubMed Web of Science ®Google Scholar
• Badalato R., Wang J. M., Kelvin D., et al. Serum amyloid A is a potent chemotactic factor for monocytes. J Immunol 1993; 150: 217, A.
   Web of Science ®Google Scholar
• Tumell W., Sarra R., Glover I. D., et al. Secondary structure prediction of human SAA1. Presumptive identification of calcium and lipid binding sites. Mol Biol Med 1986; 3: 387–407
   PubMedGoogle Scholar
• Westermark G. T., Engstrom U., Westermark P. The N-terminal segment of protein AA determines its fibrillogenic property. Biochem Biophys Res Comm 1992; 182: 27–33
   PubMed Web of Science ®Google Scholar
• Syverson P. V., Sletten K, Husby G. Evolutionary aspects of protein SAA. Amyloid and amyloidosis 1990, J. B. Natvig, O. Forre, G. Husby, et al. Kluwer, Dordrecht 1991; 111–114
   Google Scholar
• Nel A. E., de Beer M. C., Shepard E. G., et al. Phosphorylation of human serum amyloid A protein by protein kinase C. Biochem J 1988; 255: 29–34
   PubMed Web of Science ®Google Scholar
• Sack G. H. Molecular cloning of human genes for serum amyloid A. Gene 1983; 21: 19–24
   PubMed Web of Science ®Google Scholar
• Sack G. H., Jr, Talbot C. C., Jr. The human serum amyloid A (SAA)-encoding gene GSAA1: nucleotide sequence and possible autocrine-collagenase inducer function. Gene 1989; 54: 509–15
   Google Scholar
• Dwulet F. E., Wallace DK, Benson M. D. Amino acid structure of multiple forms of amyloid-related serum protein SAA from a single individual. Biochemistry 1988; 27: 1677–82
   PubMed Web of Science ®Google Scholar
• Steinkasser A., Weiss E. H., Schwaeble W., et al. Heterogeneity of human serum amyloid A protein. Biochem J 1990; 268: 187–93
   PubMed Web of Science ®Google Scholar
• Beach C. M., de Beer M. C., Sipe J. D., et al. Human serum amyloid A protein. Biochem J 1992; 282: 615–20
   PubMed Web of Science ®Google Scholar
• Steel D. M., Whitehead A. S. Heterogeneous modulation of acute-phase-reactant mRNA levels by interleukin-lbeta and interleukin-6 in the human hepatoma cell line PLC/PRF/5. Biochem J 1991; 277: 477–82
   PubMed Web of Science ®Google Scholar
• Whitehead A. S., de Beer M. C., Steel D. M., et al. Identification of novel members of the serum amyloid A protein superfamily as constitutive apolipoproteins of high density lipoprotein. J Biol Chem 1992; 267: 3862–7
   PubMed Web of Science ®Google Scholar
• Brinckerhoff C. E., Mitchell T. I., Karmilowicz M. J., et al. Autocrine induction of collagenase by serum amyloid A-like and beta-2-microglobulin-like proteins. Science 1989; 243: 655–7
   PubMed Web of Science ®Google Scholar
• Li X., Liao WSL. Expression of rat serum amyloid Al gene involves both C/EBP-like and NFKB-like transcription factors. J Biol Chem 1991; 266: 15192–15201
   PubMed Web of Science ®Google Scholar
• Sipe J., Rokita H., Shirahama T., et al. Analysis of SAA gene expression in rat and mouse during acute inflammation and accelerated amyloidogenesis. Protides Biol Fluids Coll 1986; 34: 331–4
   Google Scholar
• Baltz M. L., Rowe I. F., Caspi D., et al. Acute-phase high-density lipoprotein in the rat does not contain serum amyloid A protein. Biochem J 1987; 242: 301–3
   PubMed Web of Science ®Google Scholar
• Meek R. L., Benditt E. P. Rat tissues express serum amyloid A protein-related mRNAs. J Exp Med 1989; 86: 1890–4
   Google Scholar
• De Beer M. C., de Beer F. C., Beach C. M., et al. Syrian and Armenian hamsters differ in serum amyloid A (SAA) gene expression: identification of novel Syrian hamster SAA subtypes. J Immunol 1993; 150: 5361–70
   PubMed Web of Science ®Google Scholar
• Hoffman J. S., Ericsson L. H., Eriksen N., et al. Murine tissue amyloid protein AA. NH2-terminal sequence identity with only one of two serum amyloid protein (apoS AA) gene products. J Exp Med 1984; 159: 641–6
   PubMed Web of Science ®Google Scholar
• Niewold T. A., Tooten PCJ. Purification and characterization of hamster serum amyloid A protein (SAA) by cholesteryl hemisuccinate affinity chromatography. ScandJ Immunol 1990; 31: 389–96
   PubMed Web of Science ®Google Scholar
• Kluve-Beckerman B., Liepnicks J, Benson M. D. Differential regulation of human serum amyloid A isoforms. Amyloid and amyloidosis 1990, J. B. Natvig, O. Forre, G. Husby, et al. Kluwer, Dordrecht 1991; 125–128
   Google Scholar
• Sipe J. D., Carreras I., Gonnerman W. A., et al. Characterization of the inbred CE/J mouse strain as amyloid resistant. Am J Pathol 1993; 143: 1480–5
   PubMed Web of Science ®Google Scholar
• Ancsin J., Kisilevsky R. Characterization of SAA:Laminin binding. VIIth International Symposium on Amyloidosis, (Abstract), Kingston, OntarioCanada July, 1993
   Google Scholar
• Kanda Y., Goodman D. S., Canfield R. E., et al. The amino acid sequence of human plasma prealbumin. J Biol Chem 1974; 249: 6796–6805
   PubMed Web of Science ®Google Scholar
• Blake CCF, Geisow M. J., Oatley S. J., et al. Structure of prealbumin: secondary, tertiary and quaternary interactions determined by Fourier refinement at 1.8. A. J Mol Biol 1978; 121: 339–56
   PubMed Web of Science ®Google Scholar
• Costa P. P., Figueira AS, Bravo F. R. Amyloid fibril protein related to prealbumin in familial amyloidotic polyneuropathy. Proc Natl Acad Sci USA 1978; 75: 4499–503
   PubMed Web of Science ®Google Scholar
• Blake CCF. Prealbumin and the thyroid hormone nuclear receptors. Proc R Soc Lond 1981; B211: 31–413
   Google Scholar
• Cornwell G. G., Sletten K., Olofsson B. O., et al. Prealbumin: its association with amyloid. J Clin Pathol 1987; 40: 226–31
   PubMed Web of Science ®Google Scholar
• Saraiva MJM. Familial amyloid polyneuropathy and transthyretin variants. Neuromuscular Disord 1991; 1: 3–6
   PubMedGoogle Scholar
• Smith F. R., Goodman D. S. The effects of diseases of the liver, thyroid, and kidneys on the transport of vitamin A in human plasma. J Clin Invest 1971; 50: 2426–36
   PubMed Web of Science ®Google Scholar
• Saraiva MJM, Costa PP, Goodman D. S. Familial amyloid polyneuropathy and transthyretin variants. The molecular and genetic basis of neurological disease, R. N. Rosenberg, S. B. Prusiner, S. DiMauro, et al. Butterworth, London 1992
   Google Scholar
• Jacobson D. R., Buxbaum J. N. Genetic aspects of amyloidosis. Adv Human Genet 1991; 20: 69–123
   PubMedGoogle Scholar
• Cohen A. S., Sipe J. D. Amyloidosis. Clinical immunology, R. R. Rich, T. A. Fleisher, B. D. Schwartz, et al. Mosby-Year Book, St. Louis 1994, (in press)
   Google Scholar
• Moses A. C., Rosen H. N., Moller D. E., et al. The molecular basis of dysprealbuminemic hyperthyroxinemia: identification of a point mutation in transthyretin that increases affinity for thyroxine. J Clin Invest 1990; 86: 2025–33
   PubMed Web of Science ®Google Scholar
• Fitch NJS, Akbari MT, Ramsden D. B. An inherited non-amyloidogenic transthyretin variant, [Ser6]-TTR, with increased thyroxine-binding affinity, characterized by DNA sequencing. J Endocrinol 1991; 129: 309–13
   PubMed Web of Science ®Google Scholar
• Felding P., Fex G., Westermark P., et al. Prealbumin in Swedish patients with senile systemic amyloidosis and familial amyloidotic polyneuropathy. Scand J Immunol 1985; 21: 133–40
   PubMed Web of Science ®Google Scholar
• Terry C. J., Blake CCF. Studies on the molecular arrangement in transthyretin-related familial amyloidotic polyneuropathy fibrils. Amyloid and amyloidosis 1990, J. B. Natvig, O. Forre, G. Husby, et al. Kluwer, Dordrecht 1991; 575–578
   Google Scholar
• Hamilton J. A., Steinrauf L. K., Liepniks J., et al. X-ray crystal structure of the met-30 variant of human prealbumin (transthyretin). Amyloid and amyloidosis 1990, J. B. Natvig, O. Forre, G. Husby. Kluwer, Dordrecht 1991; 579–582
   Google Scholar
• Wahlquist J., Thylen C., Haettner E., et al. Structure of transthyretin molecules in amyloid fibrils from the vitreous body in individuals with the met30 mutation. Amyloid and amyloidosis 1990, J. B. Natvig, O. Forre, G. Husby. Kluwer, Dordrecht 1991; 587–590
   Google Scholar
• Migita S., Takegami M, Benson M. D. Disulfide bond formation of transthyretin (TTR) as possible initial step of familial amyloid polyneuropathy (FAP). Amyloid and amyloidosis 1990, J. B. Natvig, O. Forre, G. Husby, et al. Kluwer, Dordrecht 1991; 583–586
   Google Scholar
• Almeida MdR, Altland K., Rauh S., et al. Characterization of a basic transthyretin variant-TTR arg 102 in the German population. Biochim Biophys Acta 1991; 1097: 224–226
   PubMedGoogle Scholar
• Zannis V. I., Kardassis D, Zanni E. E. Genetic mutations affecting human lipoproteins, their receptors, and their enzymes. Adv Hum Genet 1993; 21: 145–319
   PubMedGoogle Scholar
• Nichols W. C., Dwulet F. E., Liepnicks J., et al. Variant apolipoprotein Al as a major constituent of a human hereditary amyloid. Biochem Biophys Res Commun 1988; 156: 762–768
   PubMed Web of Science ®Google Scholar
• Jones L. A., Harding J. A., Cohen A. S., et al. New U.S.A. family has apolipoprotein AI (arg26) variant. Amyloid and amyloidosis1990, J. B. Natvig, O. Forre, G. Husby. Dordrecht Kluwer. 1991; 385–388
   Google Scholar
• Benson M. D., Rader D. J., Schaefer J. R., et al. In vivo metabolism of a mutant apolipoprotein A-I (arg26) associated with hereditary amyloidosis. Amyloid and amyloidosis 1990, J. B. Natvig, O. Forre, G. Husby. Kluwer, Dordrecht 1991; 381–384
   Google Scholar
• Takeshita S., Hosokawa M., Lino M., et al. Spontaneous Age-Associated Amyloidosis in Senescence-Accelerated Mouse (SAM. Mech Aging Dev 1983; 20: 13–23
   Web of Science ®Google Scholar
• Scheinberg M. A., Cathcart E. S., Eastcott J. W., et al. The SJL/J mouse: a new model for spontaneous age-associated amyloidosis. I. Morphologic and immunochemical aspects. Lab Invest 1976; 35: 47–54
   PubMed Web of Science ®Google Scholar
• Chai C. K. Reticular cell hyperplasia and amyloidosis in a line of mice with low leukocyte counts. Am J Pathol 1976; 85: 49–52
   PubMed Web of Science ®Google Scholar
• Warden C., Bee L., Lusis A. J., et al. The low leukocyte (LLC) mouse, a second model of “senescence-accelerated” amyloidosis associated with apolipoprotein All pro5-gln; prevalence of this substitution among inbred strains of mice. Amyloid and amyloidosis, 1990, J. B. Natvig, O. Forre, G. Husby. Kluwer, Dordrecht 1991; 397–401
   Google Scholar
• Higuchi K., Naiki H., Kitagawa K., et al. Mouse senile amyloidosis. ASam amyloidosis in mice presents universal as a systemic age-associated amyloidosis. Virch Archiv B Cell Pathol 1991; 60: 231–8
   Google Scholar
• Ando Y., Tanaka Y., Ueyama H., et al. Changed affinity of apolipoprotein AII to high-density lipoprotein (HDL) in patients with familial amyloidotic polyneuropathy (FAP) type I. VIIth International Symposium on Amyloidosis, Kingston, Ontario, Canada(Abstract). 1993
   Google Scholar
• McLaughlin P. J., Gooch J. T., Mannherz H-G, et al. Structure of gelsolin segment 1-actin complex and the mechanism of filament severing. Nature 1993; 364: 685–92
   PubMed Web of Science ®Google Scholar
• Maury CPJ, Alii K, Baumann M. Finnish hereditary amyloidosis. Amino acid sequence homology between the amyloid fibril protein and human plasma gelsoline. FEBS Lett 1990; 260: 85–7
   PubMed Web of Science ®Google Scholar
• Palsdottir A., Abrahamson M., Thorsteinsson L., et al. Mutation in cystatin c gene causes hereditary brain haemorrhage. Lancet 1988; ii: 603–4
   Google Scholar
• Fujihara S., Shimode K., Nakamura M., et al. Cerebral amyloid angiopathy associated with cerebral hemorrhage with the deposition of cystatin c: study on Japanese cases. Amyloid and amyloidosis 1990, J. B. Natvig, O. Forre, G. Husby. Kluwer, Dordrecht 1991; 365–368
   Google Scholar
• Thorsteinsson L., Georgsson G., Asgeixsson B., et al. Perturbation of processing of cystatin C in monocytes from patients with hereditary cystatin C amyloid angiopathy. Amyloid and amyloidosis 1990, J. B. Natvig, O. Forre, G. Husby. Kluwer, Dordrecht 1991; 357–60
   Google Scholar
• Uemichi T., Liepnicks JJ, Benson M. D. Fibrinogen A alpha chain variants and hereditary amyloidosis. VUth International Symposium on Amyloidosis, Kingston, Ontario, Canada (Abstract). 1993
   Google Scholar
• Pepys M. B., Hawkins P. N., Booth D. R., et al. Human lysozyme gene mutations cause hereditary systemic amyloidosis. Nature 1993; 362: 553–7
   PubMed Web of Science ®Google Scholar
• Gejyo F., Homma N., Suzuki Y., et al. Serum levels of beta-2-microglobulin as a new form of amyloid protein in patients undergoing long-term hemodialysis. N Engl J Med 1986; 314: 585–6
   PubMed Web of Science ®Google Scholar
• Connors L. H., Shirahama T., Skinner M., et al. In vitro formation of amyloid fibrils from intact beta-2-micToglobulin. Biochem Biophys Res Comm 1985; 131: 1063–8
   PubMed Web of Science ®Google Scholar
• Gejyo F., Maruyama S., Maruyama H., et al. Beta-2-microglobulin-derived amyloid and calcium in long-term dialysis patients. Amyloid and amyloidosis 1990, J. B. Natvig, O. Forre, G. Husby. Kluwer, Dordrecht 1991; 377–380
   Google Scholar
• Westermark P., Stenkvist B. A new method for the diagnosis of systemic amyloidosis. Arch Intern Med 1973; 132: 522–3
   PubMedGoogle Scholar
• Merlini G., Limido D., Bellotti V, et al. Beta-2-microglobulin does not deposit in abdominal fat tissue of long-term hemodialysis patients. Amyloid and amyloidosis 1990, J. B. Natvig, O. Forre, G. Husby. Kluwer, Dordrecht 1991; 801–804
   Google Scholar
• Glenner G. G. Alzheimer's disease: its proteins and genes. Cell 1988; 52: 307–8
   PubMed Web of Science ®Google Scholar
• Masters C. L., Simms G., Weinman N. A., et al. Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc Natl Acad Sci USA 1985; 82: 4245–9
   PubMed Web of Science ®Google Scholar
• Van Nostrand W. E., Wagner S. L., Suzuki M., et al. Protease nexin-II, a potent anti-chymotrypsin, show identity to amyloid beta-protein precursor. Nature 1989; 341: 546–9
   PubMed Web of Science ®Google Scholar
• Selkoe D. J. Deciphering Alzheimer's disease. Science 1990; 248: 1058–60
   PubMed Web of Science ®Google Scholar
• Esch F. S., Keim P. S., Beattie E. C., et al. Cleavage of amyloid beta peptide during constitutive processing of its precursor. Science 1990; 248: 1122
   PubMed Web of Science ®Google Scholar
• Seubert P., Vigo-Pelfrey C., Exch F., et al. Isolation and quantification of soluble Alzheimer's beta-peptide from biological fluids. Nature 1992; 359: 325–7
   PubMed Web of Science ®Google Scholar
• Abraham C. R., Selkoe DJ, Potter H. Immunochemical identification of the serine protease inhibitor alpha-1-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease. Cell 1988; 52: 487–501
   PubMed Web of Science ®Google Scholar
• Koj A., Gauldie J, Baumann H. Biological perspectives of cytokine and hormone networks. Acute phase proteins, molecular biology and biochemistry and clinical applications, A Mackiewicz, I. Kushner, H. Baumann. CRC Press, Boca Raton 1993; 275–287
   Google Scholar
• Baumann H., Wong G. G. Hepatocyte stimulating factor III shares structural and functional identity with leukemia inhibitory factor. J Immunol 1989; 143: 1161–7
   Web of Science ®Google Scholar
• Giulian D., Baker T. J., Shih L-CN, et al. Interleukin 1 of the central nervous system is produced by ameboid microglia. J Exp Med 1986; 164: 594–604
   PubMed Web of Science ®Google Scholar
• Goldgaber D., Harris H. W., Hla T., et al. Interleukin 1 regulates synthesis of amyloid beta-protein precursor mRNA in human endothelial cells. Proc Natl Acad Sci USA 1989; 86: 7606–10
   PubMed Web of Science ®Google Scholar
• Vandenabeele P., Fiers W. Is amyloidogenesis during Alzheimer's disease due to an II-1/IL-6-mediated “acute phase response” in the brain%. Immunol Today 1991; 12: 217–9
   PubMedGoogle Scholar
• Levy E., Carman M. D., Fernandez-Madrid L. I., et al. Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type. Science 1990; 248: 1124–6
   PubMed Web of Science ®Google Scholar
• Prusiner S. B. Molecular biology of prion diseases. Science 1991; 252: 1515–22
   PubMed Web of Science ®Google Scholar
• Weissmann C. A “unified theory” of prion propagation. Nature 1991; 352: 679–82
   PubMed Web of Science ®Google Scholar
• Bruce M. E., Dickinson A. G. Biological evidence that the scrapie agent has an independent genome. J Gen Virol 1987; 68: 79–89
   PubMed Web of Science ®Google Scholar
• Pearse AGE. APUD: concept, tumours, molecular markers and amyloid. Mikroskopie (Wien) 1980; 36: 257–69
   PubMedGoogle Scholar
• Westermark P., Johnson K. H. Polypeptide hormones and amyloid. Amyloid and amyloidosis 1990, J. B. Natvig, O. Forre, G. Husby, et al. Kluwer, Dordrecht 1991; 427–32
   Google Scholar
• Surewicz W. K., Mantsch H. H., Stahl G. L., et al. Infrared spectroscopic evidence of conformational transitions of an atrial natriuretic peptide. Proc Natl Acad Sci USA 1987; 84: 7028–30
   PubMed Web of Science ®Google Scholar
• Westermark P., Wernstedt C., Wilander E., et al. A novel peptide in the calcitonin gene related peptide family as an amyloid fibril protein in the endocrine pancreas. Biochem Biophys Res Commun 1986; 140: 827–31
   PubMed Web of Science ®Google Scholar
• Sanke T., Bell G. L., Sample C., et al. An islet amyloid peptide is derived from an 89-amino acid precursor by proteolytic processing. J Biol Chem 1988; 263: 17243–6
   PubMed Web of Science ®Google Scholar
• Betsholtz C., Svensson V., Rorsman F., et al. Islet amyloid polypeptide (LAPP): cDNA cloning and identification of an amyloidogenic region associated with the species-specific occurrence of age-related diabetes mellitus. Exp Cell Res 1989; 183: 484–93
   PubMed Web of Science ®Google Scholar
• Mosselman S., Hoppener J. W., Jansz H. S., et al. The complete islet amyloid polypeptide precursor is encoded by two exons. FEBS Lett 1989; 247: 154–8
   PubMed Web of Science ®Google Scholar
• Johnson K. H., O'Brien T. D., Hayden D. W., et al. Immunolocalization of islet amyloid polypeptide (LAPP) in pancreatic beta cells by means of peroxidase-anti-peroxidase (PAP) and protein-A gold techniques. Am J Pathol 1988; 130: 1–8
   PubMed Web of Science ®Google Scholar
• Lukinius A., Wilander E., Westermark G. T., et al. Co-localization of islet amyloid polypeptide and insulin in the B cell secretory granules of the human pancreatic islets. Diabetologia 1989; 32: 240–4
   PubMed Web of Science ®Google Scholar
• Clark A, Edwards C. A., Ostle L. R., et al. Localization of islet amyloid peptide in lipofuscin bodies and secretory granules of human B-cells and in islets of type-2 diabetic subjects. Cell Tissue Res 1989; 257: 179–85
   PubMed Web of Science ®Google Scholar
• Betsholtz C., Christmanson L., Engstrom U., et al. Structure of cat islet amyloid polypeptide and identification of amino acid residues of potential significance for islet amyloid formation. Diabetes 1990; 39: 118–22
   PubMed Web of Science ®Google Scholar
• Sletten K., Westennark P, Natvig J. B. Characterization of amyloid fibril proteins from medullary carcinoma of the thyroid. J Exp Med 1976; 143: 993–8
   PubMed Web of Science ®Google Scholar
• Storkel S., Schneider H. M., Muntefering H., et al. Iatrogenic, insulin-dependent, local amyloidosis. Lab Invest 1983; 48: 108–11
   PubMed Web of Science ®Google Scholar
• Dische F. E., Wemstedt C., Westermark G. T., et al. Insulin as an amyloid-fibril protein at sites of repeated insulin injections in a diabetic patient. Diabetologia 1988; 31: 158–61
   PubMed Web of Science ®Google Scholar
• Hellman U., Wemstedt C, Westermark P., et al. Amino acid sequence from degu islet amyloid-derived insulin shows unique sequence characteristics. Biochem Biophys Res Commun 1990; 169: 571–7
   PubMed Web of Science ®Google Scholar
• Johansson B., Wemstedt C, Westermark P. Atrial natriuretic peptide deposited as atrial amyloid fibrils. 1987; 148: 1087–92
   Google Scholar
• Linke R. P., Voight C., Storkel F. S., et al. N-terminal amino acid sequence analysis indicates mat isolated atrial amyloid is derived from atrial natriuretic peptide. Virchows Arch B Cell Pathol 1988; 55: 125–7
   Google Scholar
• Yoneda K., Watanabe H, Yanagihara M., et al. Immunochemical staining properties of amyloid with anti-keratin antibodies using formalin fixed, paraffin-embedded sections. J Cutaneous Pathol 1989; 16: 133–6
   PubMed Web of Science ®Google Scholar
• Gueft B. The analogy of amyloid and keratin as suggested by X-ray, amino acid and ultrastruc-tural analysis. Mt Sinai J Med 1972; 39: 91–102
   PubMedGoogle Scholar
• Cohen A. S. General introduction and a brief history of amyloidosis. Amyloidosis, J. Marrink, M. H. van Rijswijk. Martinus Nijhoff, Dordrecht 1986; 3–19
   Google Scholar
• Bennhold H. Eine spezifische amyloidfarbung mit kongorot. Muench Med Wochenschr 1922; 69: 1537–8
   Google Scholar
• Kyle R. A., Gertz M. A. Systemic amyloidosis. Crit Rev Oncol/Hematol 1990; 10: 49–87
   PubMed Web of Science ®Google Scholar
• Osserman E. F., Sherman W. H., Kyle R. A. Further studies of therapy of amyloidosis with dimethylsulfoxide. Amyloid and amyloidosis, G. G. Glenner, P. P. Costa, F. Freitas. Excerpta Medica, Amsterdam 1980; 563–569
   Google Scholar
• Van Rijswijk M. H., Ruinen L., Donker J. M., et al. Successful treatment with dimethylsulfoxide of human amyloidosis secondary to rheumatoid arthritis. Amyloid and amyloidosis, G. G. Glenner, P. P. Costa, F. Freitas. Excerpta Medica, Amsterdam 1980; 570–577
   Google Scholar
• Varga J., Flinn MSM, Shirahama T., et al. The induction of accelerated murine amyloid with human splenic extract. Virch Arch (Cell Pathol) 1986; 51: 177–85
   Google Scholar
• Zemer D., Pras M., Sohar E., et al. Colchicine in the prevention and treatment of the amyloidosis of familial Mediterranean fever. N Engl J Med 1986; 314: 1001–5
   PubMed Web of Science ®Google Scholar
• Brandwein S. R., Medsger T. S., Skinner M., et al. Colchicine in acute inflammation. J Rheumatol 1984; 11: 597–601
   PubMed Web of Science ®Google Scholar
• Brandwein S. R., Sipe J. D., Skinner M., et al. Effect of colchicine on experimental amyloidosis in two CBA/J mouse models. Chronic inflammatory stimulation and administration of amyloid-enhancing factor during acute inflammation. Lab Invest 1985; 52: 319–25
   PubMed Web of Science ®Google Scholar